The US International Trade Commission declined to review a ruling that Apple's redesigned blood-oxygen feature in the Apple Watch does not infringe Masimo's patents, effectively ending the case and averting a US ban. The decision caps a six-year dispute that previously led to an import exclusion order and prompted Apple to rework the pulse-oximetry system to keep the feature available.
Deutsch
English
Español
Français
Italiano
Nederlands
Polski
Português
Русский
Türkçe
Svenska
Chinese
Magyar